IL-38: A new factor in rheumatoid arthritis

Shinichi Takenaka, Shinjiro Kaieda, Tomotaka Kawayama, Masanobu Matsuoka, Yoichiro Kaku, Takashi Kinoshita, Yuki Sakazaki, Masaki Okamoto, Masaki Tominaga, Katsuya Kanesaki,

Biochemistry and Biophysics Reports · 2015 · 68 citations · 19 references

DOIFull text

Open access

Concepts

Abstract

mice showed greater disease severity, accompanied by higher IL-1β and IL-6 gene expression in the joints. Therefore, IL-38 acts as an inhibitor of the pathogenesis of autoantibody-induced arthritis in mice and may have a role in the development or progression of RA in humans.

References

19